Contrary to tRF-03357, a tRF-5s derived from tRNA-Glu has been elucidated to target the breast cancer anti-estrogen resistance protein 3 (BCAR3) and hence to inhibit the proliferation of ovarian carcinoma cells (121). The gene discussed is BCAR3; the disease is ovarian carcinoma.